Free T3
(Free triiodothyronine)
Material: | 1 ml serum |
Methods: | Ligandenassays → Chemilumineszenz-Immunoassay (CLIA) | Reference range | Adults: 1,7 – 3,7 pg/ml
Children: Up to 1 year of age: 2,32 pg/ml – 4,84 pg/ml Up to 12 years of age: 2,79 pg/ml – 4,42 pg/ml
Girls: Up to 15 years of age: 2,50 pg/ml – 3,95 pg/ml Up to 19 years of age: 2,31 pg/ml – 3,71 pg/ml
Boys: Up to 15 years of age: 2,89 pg/ml – 4,33 pg/ml Up to 19 years of age: 2,25 pg/ml – 3,85 pg/ml |
Indication | Only utilizable in connection with the evaluation of TSH and fT4 for the assessment of the thyroid function |
Please note | In rare cases, an isolated T3-hyperthyroidism can occur. However, an fT3 increase can also be present initially in the early stages of a hyperthyroidism in the context of an autoimmune thyropathy. Low fT3 levels may also point towards a low T3-syndrome. This occurs in serious general illnesses and is a non-therapy dependent adaptation process of metabolism. A conversion to a low T3-low T4-syndrome is classed as unfavorable for prognosis. T3 is formed primarily in the peripheral tissue by deiodization from T4. Whether fT3 levels measured in the peripheral blood reliably reflect the actual concentration in the organs (especially the brain), is currently the subject of research. In case of hypothyroidism, partially elevated fT3 levels may be measured in the early stages as a sign of a reactive conversion increase, and are therefore not meaningful. |
Accredited | ja |
More Results for the letter F
- Factor II activity (FACT01)
- Prothrombin
- Factor II mutation (FACT02)
- Prothrombin mutation G20210A
- Factor IX activity (FACT11)
- Factor V activity (FACT03)
- Factor V mutation Leiden (FACT04)
- Mutation: G1691A
- Factor VII activity (FACT05)
- Factor VIII activity (FACT06)
- Factor VIII inhibitor (FACT10)
- Factor VIII ristocetin cofactor (von Willebrand factor activity) (FACT08)
- vWF:activity
- Factor VIII von Willebrand factor antigen (FACT07)
- vWF:Ag
- Factor VIII von Willebrand multimers (FACT09)
- Factor X activity (FACT12)
- Factor XI activity (FACT13)
- Factor XII activity (FACT14)
- Hageman-Factor
- Factor XIII activity (FACT15)
- Syn.: fibrin stabilising factor
- Factor–II–activity (FAK2)
- Prothrombin
- Factor-II-mutation (FAK2GM)
- Prothrombin mutation G20210A
- Factor-IX-activity (FAK9)
- Factor-V-activity (FAK5)
- Factor-V-mutation Leiden (FAK5GM)
- Mutation: G1691A
- Factor-VII-activity (FAK7)
- Factor-VIII-activity (FAK8)
- Factor-VIII-inhibitor (FAK8IN)
- Bethesda assay
- Factor-X-activity (FAK10)
- Factor-XI-activity (FAK11)
- Factor-XII-activity (FAK12)
- Hageman factor
- Factor-XIII-activity (FAK13)
- Fibrin-stabilizing factor
- Fasciola hepatica (FASCI, FASCG)
- Common liver fluke
- Fat, total in stool (FETT1)
- Fatty acids, long-chained (LAFS)
- LCFA